Pro MedicusPMDIY 77 Days Payable is 10,917.89 as of Dec. 2025, which is 1239% above its 10-year median of 815.18. GuruFocus rates PMDIY with a GF Score™ of 77/100 and a GF Value™ of $31.72 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 606 Healthcare Providers & Services companies, Pro Medicus ranks better than 99.01% on this metric.
The historical rank and industry rank for Pro Medicus's Days Payable or its related term are showing as below:
PMDIY'
s Days Payable Range Over the Past 10 Years
Min: 164.5 Med: 815.18 Max: 11064.47
Current: 11064.47
During the past 13 years, Pro Medicus's highest Days Payable was 11064.47. The lowest was 164.50. And the median was 815.18.
PMDIY's Days Payable is ranked better than 99.01% of 606
companies
in the Healthcare Providers & Services industry
Industry Median: 58.205
vs PMDIY: 11064.47
Pro Medicus's Days Payable
increased
from Dec. 2024 (6,946.41) to Dec. 2025 (10,917.89).
It may suggest that Pro Medicusdelayed paying its suppliers.
Pro Medicus Days Payable Related Terms
Pro Medicus Days Payable Historical Data
* Premium members only.
The historical data trend for Pro Medicus's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Pro Medicus's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pro Medicus Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Pro Medicus's Days Payable distribution charts can be found below:
* The bar in red indicates where Pro Medicus's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Pro Medicus's Days Payable for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pro Medicus (PMDIY) has a Days Payable of 10,917.89 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Pro Medicus and its competitors. This is 1239% above median its historical median of 815.18. Over the past decade, Pro Medicus' Days Payable has ranged from 164.50 to 11,064.47. According to the industry distribution chart, Pro Medicus ranks #6 out of 606 companies in the Healthcare Providers & Services industry, placing it in the top 1%.
Is Pro Medicus' Days Payable too high?
Pro Medicus' current Days Payable of 10,917.89 is 1239% above median its 10-year median of 815.18. Over the past 10 years, this metric has ranged from a low of 164.50 to a high of 11,064.47. The Healthcare Providers & Services industry median Days Payable is 58.21. Pro Medicus' value of 10,917.89 is 18657.6% above this industry median. Based on the distribution chart, Pro Medicus ranks #6 out of 606 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Pro Medicus has a GF Score™ of 77/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Pro Medicus' Days Payable compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Pro Medicus ranks #6 out of 606 companies for Days Payable. This places Pro Medicus in the top 1% of its industry — outperforming the majority of peers. The industry median Days Payable is 58.21. Pro Medicus' value of 10,917.89 is 18657.6% above this benchmark. Historically, Pro Medicus' own Days Payable has ranged from 164.50 to 11,064.47 over the past decade. While the company's 10-year median is 815.18 vs. the industry median of 58.21, Pro Medicus has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 58.21, based on 606 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pro Medicus's current Days Payable of 10,917.89 is 18657.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Pro Medicus and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 58.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pro Medicus's current Days Payable is 10,917.89, which is 1239% above median its own 10-year median of 815.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pro Medicus stock overvalued right now?
Based on GuruFocus' analysis, Pro Medicus (PMDIY) is currently considered Significantly Undervalued. The stock's GF Value™ is $31.72, compared to a current price of $24.45 — trading 22.9% below its estimated fair value. The current Days Payable is 10,917.89, which is 1239% above median its 10-year median of 815.18 and 18657.6% above the Healthcare Providers & Services industry median of 58.21. Pro Medicus' overall GF Score™ is 77/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Pro Medicus (PMDIY), the current Days Payable is 10,917.89 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pro Medicus (PMDIY) Overvalued in 2026?
Based on GuruFocus' analysis, Pro Medicus stock appears to be undervalued.
The current stock price of $24.45 is trading 22.9% below its estimated GF Value™ of $31.72.
GuruFocus considers Pro Medicus to be Significantly Undervalued.
Key valuation signals for PMDIY:
Days Payable: 10,917.89 (1239% above median its 10-year median of 815.18)
GF Value™: $31.72 vs. price of $24.45 (22.9% below fair value)
Industry Position: 18657.6% above the Healthcare Providers & Services median (#6 of 606)
No single metric tells the full story. See the PMDIY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pro Medicus is a healthcare IT company specializing in radiology imaging software. Its main product, Visage 7, is a clinical desktop application that radiologists use to view, enhance, and manipulate images from any device and make a diagnosis. Its main customers are US private academic hospitals. In fiscal 2025, Pro Medicus earned 90% of revenue in North America, 8% from Australia, and the remaining 2% in Europe.
77GF Score
Get the complete analysis for PMDIY
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PMDIY has been successfully added to your 
